Basic Sinequan Information

• INN (International Nonproprietary Name): Doxepin.
• Brand Names Available In Canada (English): Generics supplied by manufacturers such as Mylan and Teva; Sinequan is a historic brand (USA/UK) with generics commonly used internationally.
• ATC Code: N06AA12 (Tricyclic antidepressant).
• Forms & Dosages: Capsules are most common (10 mg, 25 mg, 50 mg, 75 mg, 100 mg). Oral solution (10 mg/mL) and low-dose tablets (3 mg, 6 mg) exist in some markets but are not commonly supplied in Canada.
• Manufacturers In Canada (English): Mylan and Teva are listed among common generic suppliers; local distribution varies by wholesaler.
• Registration Status In Canada (English): Marketed as a prescription medicine (Rx); generic approvals are prevalent.
• OTC / Rx Classification: Prescription only (Rx).
• Standard Dosages Per Condition: Depression/Anxiety—adult starting dose typically around 75 mg/day with usual ranges 75–150 mg/day (maximums reported up to 300 mg/day). Insomnia (low-dose formulations internationally) — 3–6 mg at bedtime.
• Storage & Transport: Store at room temperature (15–30°C), protect from moisture and excessive heat; transport in original packaging.
• Missed Dose / Overdose Advice: If a dose is missed, take when remembered unless close to the next dose; do not double doses. In overdose, seek immediate medical attention for symptoms such as severe drowsiness, confusion, arrhythmias or seizures.

Availability & Price Landscape

Want to know where to find sinequan or doxepin in Canada and what it costs?

Doxepin is prescription-only in Canada and availability varies by chain and province.

Major national retailers such as Shoppers Drug Mart, Rexall and London Drugs (western provinces) may stock generic doxepin capsules, but actual on-shelf supply depends on provincial demand and local wholesalers.

Quebec chains such as Jean Coutu can carry generic doxepin but stock levels are similarly variable.

Online Canadian pharmacies commonly list doxepin capsule products and require an e-prescription upload and verification before dispensing.

Some online pharmacies will not ship to provinces with stricter dispensing rules without local prescriber verification.

Provincial drug plans (Ontario Drug Benefit, BC PharmaCare, RAMQ) treat TCAs differently — many list them on limited formularies and may require special authorisations for long-term reimbursement.

Price ranges depend on package size and manufacturer, but typical retail costs for generics are in the low tens of CAD for 30-capsule packs, with variation by province and pharmacy.

Brand Sinequan is not commonly sold domestically; generics from Mylan or Teva are the usual supply sources.

Major National Pharmacy Chains

Are the big chains reliable sources for doxepin?

Shoppers Drug Mart routinely dispenses prescription antidepressants and offers pharmacist counselling at pickup.

Rexall and London Drugs also dispense doxepin where local inventory allows, with London Drugs serving Western Canada prominently.

Jean Coutu is a key option in Quebec for local patients seeking pharmacist support and prescription transfer assistance.

Availability at each chain depends on provincial demand and the wholesaler supplying that region.

Online Pharmacy Trends In Canada

Do online stores make access easier?

Many licensed Canadian online pharmacies list generic doxepin and accept e-prescriptions or uploaded PDFs for verification.

Verification calls or pharmacist follow-up are common before shipping to ensure safety and compliance with provincial rules.

Some pharmacies restrict shipping to certain provinces unless a local prescriber can confirm the prescription.

Comparison shopping between in-store and online pricing is common among Canadian patients seeking the best out-of-pocket cost.

Price Ranges By Package Size

How much should a patient expect to pay?

Typical pricing for a 30-capsule bottle of generic doxepin is in the low tens of Canadian dollars, but this varies by manufacturer and province.

Larger bottle sizes or pharmacy bulk packs offer lower per-capsule cost, while specialty formulations or imported low-dose tablets may cost more or require special-order fees.

Provincial coverage and co-pay rules will affect final out-of-pocket cost; some patients apply for prior authorisation under provincial formularies for chronic use.

Canadian Patient Insights & Satisfaction Levels

What are real Canadian patients saying about sinequan and doxepin?

Online forums and review platforms reflect practical experience with benefits and drawbacks of the drug.

Threads on Reddit (r/CanadaHealth, r/mentalhealth), HealthBoards and local Facebook groups often describe doxepin as effective for sleep and as a useful option when SSRIs are poorly tolerated.

Common patient-reported positives include rapid sedative benefit for insomnia and helpful mood improvement in some cases.

Frequent patient-reported challenges are strong drowsiness, dry mouth and constipation, often prompting evening dosing to reduce daytime impact.

Access problems appear repeatedly: prescription hurdles, variability in pharmacist verification procedures and provincial formulary denials create frustration.

Patients in Quebec commonly report easier access through community health centres, while those in remote regions note supply delays.

Satisfaction tends to be higher when prescribers and pharmacists provide clear counselling about dosing, interactions and monitoring.

Forum And Review Platforms

Where do Canadians share experience?

Reddit Canada subforums and HealthBoards show many practical tips about starting doses, timing and dealing with side effects.

Local Facebook support groups and patient reviews at pharmacy sites often note price-shopping strategies and the value of pharmacist counselling.

Reported Benefits And Challenges From Canadian Patients

Top reported benefits and side effects:

• Benefits: improved sleep, sedation for evening dosing, mood benefits for some patients who cannot tolerate SSRIs.
• Side Effects: drowsiness, dry mouth, constipation, blurred vision, urinary hesitancy, weight gain, orthostatic dizziness.

Sample anonymized patient quotes:

• "Helps me sleep through the night when other meds made me restless."
• "Stopped the SSRI because of nausea — doxepin helped my mood but I needed to take it at night."
• "My pharmacist in Halifax warned me about dry mouth and monitoring my blood pressure — good counselling."

Product Overview & Brand Variants

What exactly is sinequan and how does it appear in Canada?

The International Nonproprietary Name (INN) is doxepin.

Historically Sinequan was the common brand in the USA and UK, but generics now supply most markets.

Silenor is a low-dose doxepin tablet used for insomnia in the USA, available as 3 mg and 6 mg tablets, but these low-dose tablets are less commonly supplied in Canada.

Canadian markets typically use generic doxepin capsules in strengths 10 mg, 25 mg, 50 mg, 75 mg and 100 mg.

Health Canada classifies doxepin as prescription-only and marketed products carry a Drug Identification Number (DIN) when approved.

Packaging in Canada varies between bottles and blister packs depending on the manufacturer and distributor.

INN And Brand Names Used In Canada

Doxepin is the INN used clinically.

Generics from Mylan, Teva and other suppliers are the primary brands available to Canadian pharmacies.

Sinequan remains a recognised historical brand name but is not commonly marketed domestically as a branded product.

Legal Classification Under Health Canada

Health Canada requires prescription-only status for doxepin.

Products sold with a Canadian DIN have been reviewed for quality and approved indications.

Indications In Local Canadian Medical Practice

When do Canadian prescribers reach for doxepin?

Health Canada–labelled indications align with depressive disorders and certain anxiety disorders depending on the product monograph.

Clinicians commonly prescribe doxepin for major depressive disorder and some anxiety-spectrum conditions.

Low-dose doxepin formulations used for insomnia internationally (3–6 mg) are not widely available in Canadian-labelled form, though some prescribers use low-dose strategies off-label.

Off-label use in Canada includes neuropathic pain and chronic pruritus in dermatology given doxepin’s antihistaminic and neuromodulatory effects.

Off-label prescribing is documented in charts and often justified when seeking provincial reimbursement, with family physicians and psychiatrists noting prior trials of SSRIs or SNRIs.

Approved Uses (Health Canada DIN Context)

Primary DIN-labelled uses focus on depression and related mood disorders where a tricyclic antidepressant is indicated.

Specific product monographs outline approved indications tied to the DIN on marketed formulations.

Off-Label Patterns In Canadian Healthcare

Common off-label rationales include analgesic benefit for neuropathic pain, sedation for insomnia at low doses, and antipruritic effects for chronic itch.

When used off-label, clinicians document rationale and monitor outcomes to support safety and any funding requests.

How It Works In The Body

How does doxepin affect mood and sleep in plain language?

Doxepin is a tricyclic antidepressant that raises levels of certain mood-related neurotransmitters by blocking their reuptake.

It also strongly blocks histamine H1 receptors, producing sedative effects that explain its usefulness for sleep at low doses.

Anticholinergic and alpha-adrenergic blockade explain symptoms such as dry mouth, blurred vision, urinary retention and orthostatic hypotension.

Clinically, doxepin inhibits reuptake of norepinephrine and serotonin and has significant antihistaminic activity (ATC code N06AA12).

Hepatic metabolism via cytochrome systems gives rise to interaction potential with other drugs metabolized by the liver.

Health Canada monographs emphasise cardiac considerations and interactions — conduct screening for conduction disease or QT-prolonging combinations where indicated.

Layman’s Explanation

Think of doxepin as a medication that calms overactive brain signalling and blocks histamine, so it can lift mood and make sleep easier for some people.

Clinical Detail From Health Canada Resources

Key mechanistic points include inhibition of norepinephrine and serotonin reuptake and high H1 receptor antagonism.

Monitor for anticholinergic burden and drug–drug interactions, and use caution in patients with cardiac conduction concerns.

Dosage & Administration

What dose should a Canadian patient expect to start on?

For depression and anxiety, typical adult starting doses are around 75 mg/day, often given at bedtime or divided, with usual ranges of 75–150 mg/day and specialist-managed maxima up to 300 mg/day.

For insomnia, international low-dose regimens mirror Silenor use at 3–6 mg at bedtime, though these tablets are less commonly supplied in Canada.

Prescribers in Canada generally start at the lower end and titrate slowly, documenting dose changes and responses.

Elderly patients should begin on lower doses such as 25–50 mg/day with slow titration because of higher anticholinergic sensitivity and fall risk.

Hepatic or renal impairment calls for reduced starting doses and closer monitoring due to altered metabolism.

Children under 12 are not recommended to use doxepin and adolescents require specialist input.

Standard Regimens Per Canadian Guidelines

Start low, go slow: document prior antidepressant trials where appropriate and adjust based on response and tolerability.

Adjustments By Patient Type

Elderly: lower starting dose, orthostatic monitoring and fall precautions.

Hepatic/Renal Impairment: reduce dose and monitor clinically.

Pregnancy/Lactation: use only if clearly needed and consult specialist guidance.

Contraindications & Side Effects

Who should not take doxepin, and what common side effects should patients expect?

Absolute contraindications include known hypersensitivity to doxepin or other tricyclics, narrow-angle glaucoma, urinary retention and MAOI use within the prior 14 days.

Common side effects listed in product information are drowsiness, dry mouth, dizziness, blurred vision, constipation, urinary retention, weight gain and orthostatic hypotension.

Serious but less frequent events include cardiac conduction abnormalities, seizures, severe rash and behavioural changes; overdose can be life-threatening.

Canadian pharmacovigilance emphasises fall risk in the elderly and anticholinergic burden; prescribers screen for QT-risk drugs and pre-existing cardiac disease.

Counselling should include urgent signs such as palpitations, fainting, severe confusion or suicidal ideation.

Common (Health Canada-Approved List)

Drowsiness and anticholinergic symptoms are the most commonly reported effects.

Rare But Serious (Canadian Pharmacovigilance Data)

Cardiac arrhythmias and seizures are rare but potentially severe; monitor higher-risk patients closely and advise immediate medical care when alarming symptoms occur.

Comparable Medicines In Canada

What are realistic alternatives to doxepin in Canadian practice?

Other TCAs include amitriptyline, nortriptyline and imipramine; modern first-line alternatives are SSRIs such as sertraline and fluoxetine.

Amitriptyline often provides analgesic benefit for neuropathic pain but carries a higher anticholinergic burden.

Nortriptyline may be better tolerated in some older adults due to a somewhat lower anticholinergic profile.

SSRIs are more commonly used as first-line antidepressants because of a more favourable side-effect profile for many patients.

Provincial formularies sometimes prefer older TCAs for cost reasons but may require prior authorisation for long-term coverage.

Alternatives Table

Pros And Cons List

Pros of doxepin: effective sedative at low doses, useful when SSRIs are not tolerated, generics widely available.

Cons of doxepin: anticholinergic side effects, potential cardiac risk, and requirement for monitoring in older or medically complex patients.

Current Research & Trends

What does recent research say about doxepin use?

Between 2022 and 2025, studies have revisited the role of TCAs like doxepin, focusing on low-dose use for chronic insomnia and tolerability comparisons in treatment-resistant depression.

Case series from Canadian psychiatry and dermatology groups explore off-label applications such as neuropathic pain and chronic pruritus, highlighting modest benefits in selected patients.

Trend analyses indicate declining first-line use of TCAs for depression in favour of SSRIs, but TCAs remain valuable niche options for sleep and certain pain syndromes.

Canadian deprescribing and pharmacovigilance research stresses anticholinergic burden and fall risk, prompting dose minimization strategies and increased monitoring in frail patients.

Ongoing trials and real-world data help prescribers weigh benefits and risks in shared decision-making with patients.

Major Studies 2022–2025

• Low-dose doxepin trials for chronic insomnia showing benefit for sleep maintenance in select populations.
• Comparative tolerability studies versus SSRIs in treatment-resistant depression cohorts.
• Observational work on anticholinergic burden in elderly patients driving conservative prescribing.

Common Patient Questions In Canada

What do patients most often ask about sinequan and doxepin?

How quickly does it work: Sedation is usually immediate; antidepressant effects commonly take 1–3 weeks to become noticeable.

Is it safe in older adults: There is a higher risk of confusion, falls and anticholinergic effects — start at lower doses and monitor closely.

Will provincial drug plans cover it: Coverage varies by province and often depends on formulary listing and prior authorisation rules.

Can I drive while taking doxepin: Patients should avoid driving until they know how the medication affects them due to drowsiness.

Other frequent concerns include switching timing from SSRIs/MAOIs and safety during pregnancy or breastfeeding — specialist advice is recommended in these settings.

Where to get reliable answers: ask the prescribing physician, consult the pharmacist at Shoppers, Rexall, London Drugs or your local community pharmacy, check provincial formularies (Ontario Drug Benefit, BC PharmaCare, RAMQ) and review Health Canada monographs when needed.

Top Questions

1. How fast will I sleep better or feel mood benefits?
2. What are the main side effects to watch for?
3. Will my provincial drug plan pay for this?
4. How do I stop the drug safely when needed?

Where To Get Reliable Answers

Your prescriber and community pharmacist are primary resources for tailored advice and interaction checks.

Provincial drug plan websites and Health Canada monographs provide official coverage and safety information.

Regulatory Status

How is doxepin regulated in Canada?

Health Canada treats doxepin as a prescription medicine and approved products carry a DIN confirming regulatory review.

Manufacturers submit dossiers demonstrating bioequivalence and manufacturing standards for generic authorisation.

Clinicians and pharmacists should check the DIN when verifying product identity, formulation and approved indications, especially for imports or special orders.

Some low-dose tablet formulations used for insomnia abroad may lack a Canadian DIN and require special import routes or local compounding where permitted.

Provincial formularies reference DINs for coverage decisions and pharmacovigilance reporting relies on accurate DIN identification.

Health Canada Approval Process

Manufacturers submit evidence for quality, safety and efficacy; once approved a DIN is issued and the product can be marketed in Canada under the approved label.

DIN Number Relevance

DIN lookup is a practical step for pharmacists verifying stock, checking formulary listings and reporting adverse events.

Visual Recommendations

What visuals help patients quickly understand sinequan/doxepin?

Design an infographic summarizing at-a-glance facts: INN (doxepin), common doses, primary uses, major contraindications and provincial coverage tips.

Create a dosing timeline graphic contrasting immediate sedative onset with the 1–3 week antidepressant timeframe.

Include an interaction map highlighting high-risk combinations such as MAOIs, QT-prolonging drugs and alcohol or benzodiazepines.

Product photos should show generic capsule packaging, a pill size and colour scale, and a DIN badge so patients can match what they receive at the pharmacy.

Ensure all images include descriptive alt text and accessible colour contrast for readability across Canadian devices and for users with visual impairments.

Infographic Ideas For Canadian Context

• At-A-Glance card with DIN badge and provincial formulary icons (ODB, PharmaCare, RAMQ).
• Dosing timeline for depression vs insomnia with expected onset notes.
• Interaction map for high-risk drugs and substances.

Buying & Storage Advice

How should Canadians buy and store doxepin safely?

Purchasing requires a valid prescription for legal dispensing in Canada; in-store pick-up at Shoppers, Rexall, London Drugs or Jean Coutu allows pharmacist counselling and immediate verification for provincial plans.

Online Canadian pharmacies accept e-prescriptions or uploaded prescriptions and usually perform verification calls before shipping.

Compare in-store and online pricing while factoring provincial co-pay and shipping costs.

Cross-border ordering from the United States is common but carries regulatory, quality and insurance risks.

In our online pharmacy, sinequan is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Store doxepin at room temperature (15–30°C), protect from moisture and heat, and keep it in the original packaging.

During Canadian winters and humid summers, avoid storing medication near radiators, steam, or in a damp bathroom.

Dispose of unused product via local pharmacy take-back programs to ensure safe disposal.

In-Store Vs. Online Purchase Tips

• In-store pickup: immediate counselling and easier provincial plan processing.
• Online: price comparisons and home delivery but expect verification steps and potential shipping delays.

Proper Storage With Canadian Climate Considerations

Keep medication out of extremes — avoid freezing in winter and prolonged heat exposure in summer vehicles.

Guidelines For Proper Use

What should prescribers and pharmacists tell patients in Canada?

Use shared decision-making to discuss expected benefits, timing of effects (sedation vs antidepressant onset), a clear dosing and tapering plan, and interaction checks.

Document rationale for selecting a TCA and any prior antidepressant history, especially when seeking provincial reimbursement.

Monitoring: consider baseline ECG for patients with cardiac risk factors, regular blood pressure and orthostatic checks in older adults, and early follow-up for suicidality screening when initiating therapy.

Advise patients against abrupt cessation and provide a tapering schedule when stopping to avoid discontinuation symptoms.

Provide a printed dosing schedule, a medication wallet card showing DIN and prescriber contact, and contact information for local emergency services or provincial nurse lines for urgent questions.

Monitoring, Follow-Up And When To Seek Help

Follow up within 1–2 weeks after starting to check tolerability and again at regular intervals for symptom monitoring.

Seek urgent care for palpitations, fainting, new severe confusion, seizures, or suicidal thoughts.

Delivery Across Canada (English)